Trimethoprim-sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation.
Matthew T DonnanMiranda SiemienowiczHui Sien TayCatriona McLeanSteve PhilpotChris MasonGreg SnellIan GlaspoleRob G StirlingPublished in: Respirology case reports (2024)
Trimethoprim-sulfamethoxazole (TMP-SMX) acute respiratory distress syndrome (ARDS) is a rare, but severe complication of a commonly prescribed antibiotic. TMP-SMX typically affects young, otherwise well patients with a specific human leukocyte antigen type (HLA-B*07:02 and HLA-C*07:02). The condition is poorly understood with a unique pathological appearance and mechanism that remains unclear. Mortality rate is greater than one third. We describe the case of a previously well 18-year-old woman treated with a prolonged course of TMP-SMX for a complex urinary tract infection who developed rapidly progressive respiratory failure requiring prolonged intensive care admission, extra-corporeal membranous oxygenation, and eventual lung transplantation. No targeted treatment exists, further research is required to better understand disease pathogenetic mechanisms and potential therapeutic interventions.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- respiratory failure
- urinary tract infection
- mechanical ventilation
- endothelial cells
- multiple sclerosis
- emergency department
- early onset
- physical activity
- middle aged
- peripheral blood
- cardiovascular disease
- case report
- replacement therapy
- drug delivery
- intensive care unit
- smoking cessation